Susan S. Night, JD, LLM is Vice President of Site Engagement and Network Strategy for Translational Drug Development (TD2), a precision oncology CRO. Before joining TD2, Ms Night served as Director, Research Optimization for US Oncology Research/McKesson Specialty Health. She started her career as a healthcare management consultant with Deloitte. She holds a B.S. in Microbiology from University of Oklahoma, a JD from St. Mary’s University School of Law and an LL.M in health law from University of Houston Law Center.